[1]
Raffik, D.E. et al. 2025. Redox-Active Metabolites as Clinical Biomarkers: A Comprehensive Review of Mechanisms and Diagnostic Applications. American Journal of Biomedicine and Pharmacy. 2, 11 (Nov. 2025), 104–119. DOI:https://doi.org/10.51699/ajbp.v2i11.1743.